Cell Structure and Differentiation — Robbins & Kumar Basic Pathology

1. Cellular Adaptations to Stress

Hypertrophy

• Physiologic: Uterine smooth muscle enlargement during pregnancy (estrogen-stimulated)
• Pathologic: Cardiac hypertrophy in hypertension — mechanical stretch triggers growth factor/adrenergic release → gene expression → more myofilaments per cell
  • Notable molecular change: α-myosin heavy chain is replaced by the β-form → slower, more energetically efficient contractions
  • Sustained hypertrophy → fragmentation of myofilaments → ventricular dilation → cardiac failure

Hyperplasia

• Physiologic:
  1. Hormonal — proliferation of glandular breast epithelium at puberty/pregnancy
  2. Compensatory — liver regeneration after partial hepatectomy (begins ~12 hours post-resection)
• Pathologic: Endometrial hyperplasia (excess estrogen), benign prostatic hyperplasia (androgen/estrogen stimulation)

Key distinction: Hyperplastic processes remain controlled and cease when stimuli abate — unlike cancer, where growth-control mechanisms are permanently dysregulated. However, pathologic hyperplasia (e.g., endometrial) can be a precursor to cancer.

Atrophy

2. Cell Proliferative Capacity — Classification of Tissues

3. Cell and Tissue Regeneration

Drivers of Proliferation

• Growth factors: Produced by macrophages activated by injury, epithelial and stromal cells; bind ECM proteins and concentrate at injury sites; activate signaling pathways driving cell division
• Extracellular matrix (ECM): Cells use integrins to bind ECM proteins → integrin signaling also stimulates proliferation

Stem Cells

• Embryonal stem (ES) cells: Self-renewing, totipotential — give rise to all mature cell lineages
• Tissue (adult) stem cells: More limited self-renewal; typically restricted to tissue of residence; reside in specialized niches

One daughter cell remains a stem cell (self-renewal); the other begins to differentiate (generation of mature cell types).

Tissue-Specific Regeneration

• Epithelia (intestinal tract, skin): Rapid replacement by residual cell proliferation + stem cell differentiation, provided basement membrane is intact
• Parenchymal organs: Limited regeneration capacity; the liver is the major exception — has extraordinary regenerative capacity
  • Other organs with some capacity: pancreas, adrenal, thyroid, lung
  • After nephrectomy: compensatory hypertrophy + hyperplasia of proximal duct cells in remaining kidney
• Neurons and cardiomyocytes: Essentially no regeneration → scar formation

Critical requirement: Restoration of normal tissue architecture requires that the structural framework (supporting stroma) be intact. If this is damaged (e.g., by infection/inflammation), regeneration is incomplete and accompanied by scarring.

4. Differentiation and Anaplasia (Neoplasia Context)

Well-Differentiated Tumors

• Cells closely resemble their normal counterparts
• Benign tumors are typically well-differentiated: lipoma (mature fat cells with lipid vacuoles), chondroma (mature cartilage cells synthesizing matrix)
• Mitoses rare and of normal configuration
• Even well-differentiated malignant tumors may appear nearly normal (e.g., follicular thyroid adenocarcinoma) — malignancy revealed by invasion or metastasis

Anaplasia (Undifferentiated Tumors)

• Pleomorphism: Variation in cell and nuclear size/shape
• Abnormal nuclear morphology: Nuclei disproportionately large (N:C ratio approaches 1:1), hyperchromatic, coarse chromatin clumping, large prominent nucleoli
• Atypical mitoses: Abnormal spindles (e.g., tripolar mitotic figures)
• Giant cells: Tumor giant cells with single large nucleus or multiple nuclei
• Loss of polarity: Orientation of cells markedly disturbed

Desmoplasia

5. Dysplasia

• Cell pleomorphism
• Abnormally large, hyperchromatic nuclei
• Increased mitotic figures, often in abnormal locations (superficial epithelium)
• Loss of progressive maturation (e.g., basal cells fail to mature to surface squames)

Dysplasia ≠ cancer. Mild–moderate dysplasia may regress if inciting stimulus is removed. However, it marks tissue at increased cancer risk and is frequently found adjacent to frank malignancy.

• Cellular Adaptations to Stress — Chapter 1 (pp. 16–21)
• Cell and Tissue Regeneration — Chapter 2 (p. 67)
• Differentiation and Anaplasia — Chapter 6 (pp. 217–220)

Cell Structure & Differentiation — Related to Pathology

Robbins & Kumar Basic Pathology

1. The Cell as the Unit of Disease

"Cell injury is the basis of all disease."

Physiologic Stress
       ↓
Adaptation (new steady state)
       ↓ [if stress exceeds capacity]
Reversible Injury
       ↓ [if stress is severe/persistent]
Irreversible Injury → Cell Death (Necrosis / Apoptosis)

2. Key Organelles and Their Pathologic Significance

Morphologic Signs of Reversible Injury

• Cellular swelling (hydropic/vacuolar degeneration): distended ER → small cytoplasmic vacuoles; pallor and increased organ weight on gross exam
• Fatty change: lipid vacuoles accumulate (especially in liver, heart) — seen in hypoxia, alcohol, toxin exposure
• Increased cytoplasmic eosinophilia (H&E): progresses with severity toward necrosis

Signs of Irreversible Injury (point of no return)

1. Inability to restore mitochondrial function
2. Profound plasma membrane disturbance
3. Loss of structural nuclear integrity

3. Cell Proliferative Capacity and Pathologic Vulnerability

This classification directly explains: why myocardial infarction leads to fibrotic scar (not regeneration), why the liver can recover from partial resection, and why GI epithelium recovers from radiation mucositis.

4. Cellular Adaptations to Stress — Bridge Between Normal Structure and Pathology

Hypertrophy

• Increased cell size (not number); more organelles and structural proteins per cell
• Confined to terminally differentiated cells (neurons, cardiomyocytes, skeletal muscle)
• Pathologic example: Cardiac hypertrophy in hypertension
  • Molecular switch: α-myosin → β-myosin heavy chain (more energy-efficient but weaker)
  • Progression: Sustained hypertrophy → myofibril fragmentation → ventricular dilation → heart failure

Hyperplasia

• Increased cell number via proliferation of differentiated cells or progenitors
• Requires cell cycle entry (only possible in labile/stable cells)
• Pathologic examples: Endometrial hyperplasia (excess estrogen), benign prostatic hyperplasia
• Remains responsive to growth-control signals — distinguishes it from cancer
• Can be a precancerous substrate (endometrial hyperplasia → endometrial carcinoma)

Metaplasia

• One differentiated cell type replaced by another
• Example: Squamous metaplasia of bronchial epithelium (smoking) — columnar → squamous cells
• Controlled process, but can progress to dysplasia → carcinoma

Atrophy

• Decreased cell size and number; causes include: disuse, denervation, ischemia, malnutrition, loss of endocrine stimulation
• Mediated by ubiquitin–proteasome pathway and autophagy

5. Stem Cells, Differentiation, and Tissue Renewal

Asymmetric Division — The Defining Property

• One daughter → remains a stem cell (self-renewal)
• Other daughter → begins to differentiate (tissue regeneration)

Pathologic Relevance

6. Cell Cycle — Control and Cancer Pathology

The Normal Cell Cycle

• Cyclin D–CDK4/6 + Cyclin E–CDK2 → G₁/S transition
• Cyclin A–CDK2 → S phase
• Cyclin B–CDK1 → G₂/M transition
• CDK inhibitors (p15, p16, p18, p19; p21, p27, p57) put the brakes on

• G₁/S checkpoint: Checks DNA integrity before committing to replication
• G₂/M checkpoint: Confirms accurate replication before division

RB — Governor of the Cell Cycle (Prototype Tumor Suppressor)

• RB is the key regulator of the G₁/S checkpoint
• In G₁: Hypophosphorylated RB binds and sequesters E2F transcription factors → blocks S-phase entry
• Growth signals → Cyclin D–CDK4/6 phosphorylates RB → RB releases E2F → cyclin E transcription → S phase proceeds
• Pathologic inactivation: Both RB alleles must be lost (Knudson's "two-hit hypothesis")
  • Familial retinoblastoma: 1 germline hit + 1 somatic hit
  • Sporadic retinoblastoma: 2 somatic hits
  • RB loss also found in: osteosarcoma, breast cancer, bladder cancer, small cell lung cancer

Oncogenes — Accelerators Stuck On

• RAS (most commonly mutated oncogene; ~20% of all human tumors — highest in pancreatic adenocarcinoma): normally cycles GDP-bound (inactive) ↔ GTP-bound (active); mutant RAS is constitutively GTP-bound → persistent growth signaling
• Growth factor receptors: ERBB1 (EGF receptor) overexpressed in 80% of squamous cell lung carcinomas; HER2 (ERBB2) amplified in ~20% of breast cancers → target of trastuzumab (anti-HER2 antibody)
• Autocrine loops: Cancer cells secrete their own growth factors (e.g., glioblastoma secretes PDGF and overexpresses PDGF receptor)

Tumor Suppressor Genes — Brakes Cut

1. Driving cells into G₀ (quiescence)
2. Directing cells into post-mitotic differentiated pools (loss of replicative potential)
3. Inducing senescence
4. Triggering apoptosis

7. Differentiation as a Pathologic Parameter

In Neoplasia (Grading)

• Pleomorphism (cell and nuclear size variation)
• Hyperchromatic nuclei with coarse chromatin; large nucleoli
• High N:C ratio (approaching 1:1)
• Atypical/multipolar mitoses (e.g., tripolar spindles)
• Loss of normal polarity
• Tumor giant cells

Anaplasia arises either by dedifferentiation of mature cells during carcinogenesis, or (in stem-cell-derived tumors) by failure to differentiate in the first place.

Dysplasia — The Pre-Malignant Transition

• Disordered proliferation with architectural and cytologic abnormalities
• Features: nuclear pleomorphism, hyperchromasia, mitoses at abnormal levels, loss of progressive maturation
• When full-thickness epithelial involvement → carcinoma in situ
• Reversible at mild–moderate grade; if severe or persistent → invasive carcinoma

Summary: Cell Structure → Differentiation → Pathology

NORMAL CELL STRUCTURE
(organelles, membranes, nucleus)
         ↓ Stress / Injury
ADAPTATION (hypertrophy, hyperplasia, metaplasia, atrophy)
         ↓ Exceeds adaptive limits
CELL INJURY — reversible → irreversible
         ↓ Organelle-specific mechanisms
CELL DEATH (necrosis / apoptosis)
         
Parallel pathway:
STEM CELL POOL → Asymmetric division → Differentiation → Mature cells
         ↓ Mutations in differentiation/cell cycle genes
DYSPLASIA → ANAPLASIA → NEOPLASIA
(loss of differentiation + cell cycle checkpoint bypass = cancer)

• Chapter 1: Cell Injury, Cell Death, and Adaptations (pp. 1–22)
• Chapter 2: Tissue Renewal and Repair (pp. 67–68)
• Chapter 6: Neoplasia — Differentiation/Anaplasia (pp. 217–220), Cell Cycle (pp. 230–234)